No significant differences were observed in the incidence of adverse reactions such as leukopenia, HB reduction, thrombocytopenia, elevated alanine aminotransferase (ALT), elevated aspartate aminotransferase (AST), elevated creatinine, nausea, vomiting, radiation dermatitis, weight loss, hyponatremia, hypokalemia, skin rash and infusion reaction between the two groups (P > 0.05) (Table 4). The gene discussed is GPT; the disease is radiodermatitis.